Concerns regarding the quality measure for attention-deficit/hyperactivity disorder may limit its usefulness and its ability to promote improvement efforts.
Meredith L. Kilgore, PhD
Advertisement
Articles by Meredith L. Kilgore, PhD
Using longitudinal Medicare claims data, this study quantified the association of the Medicare Part D coverage gap with medication adherence among beneficiaries with chronic obstructive pulmonary disease.
Advertisement
Latest Updated Articles
- An Assessment of the CHIP/Medicaid Quality Measure for ADHD
January 17th 2017
Advertisement
Advertisement
Trending on AJMC
1
Legend Biotech’s CAR T-cell Therapy Shows Early Promise in SCLC, Other Tumors
2
Patient Portal Messages Outpace Office Visits
3
Flatiron’s AI-Driven Telescope Makes Data Access More User-Friendly
4
Social Factors May Match, Outpace Genetic Risk in Disease Prediction
5